Home
NTHI
NTHI News

Latest NeOnc Technologies Holdings Inc. Common Stock (NTHI) News on October 31, 2025

Meet the Companies - New to The Street's Accredited Investor Event Returns October 21-22 at Hudson Yards, NYC

ACCESS Newswire

21 days ago

Meet the Companies - New to The Street's Accredited Investor Event Returns October 21-22 at Hudson Yards, NYC

MT Newswires

22 days ago

NeOnc Technologies Unit Signs Master Services Deal With UAE's Insights Research Organization and Solutions

NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42’s IROS and Expands Board of Directors

GlobeNewswire

22 days ago

NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42’s IROS and Expands Board of Directors

ACCESS Newswire

25 days ago

New to The Street to Broadcast Tonight on Fox Business 10:30 PM PST Featuring NeOnc Technologies, FLOKI, XION, Sharps Technology, and Aeries Technology

NeOnc Technologies and Quazar Investment Set to Close $50 Million Strategic Partnership by October 23rd Following Final UAE Tax Approvals

GlobeNewswire

25 days ago

NeOnc Technologies and Quazar Investment Set to Close $50 Million Strategic Partnership by October 23rd Following Final UAE Tax Approvals

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 06/27/2025

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 06/26/2025

NeOnc Technologies Holdings Insiders Lose Out As Stock Sinks To US$3.72

Simply Wall St.

4 months ago

NeOnc Technologies Holdings Insiders Lose Out As Stock Sinks To US$3.72

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 06/25/2025

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 06/24/2025

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 06/23/2025

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 06/20/2025

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 06/18/2025

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 06/17/2025

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 06/16/2025

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 06/13/2025

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 06/12/2025

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 06/11/2025

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 06/10/2025

MT Newswires

5 months ago

NeOnc Technologies Files Prospectus for Resale of Shares

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 06/09/2025

NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs

GlobeNewswire

5 months ago

NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 06/06/2025

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 06/05/2025

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 06/04/2025

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 06/03/2025

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 06/02/2025

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 05/30/2025

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 05/29/2025

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 05/28/2025

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 05/27/2025

MT Newswires

6 months ago

Top Premarket Decliners

NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets

GlobeNewswire

7 months ago

NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets

MT Newswires

7 months ago

NeOnc Technologies Expects Full Enrollment in Phase 2a Trialfor NEO100-01 by September

NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September

GlobeNewswire

7 months ago

NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September

MT Newswires

7 months ago

NeOnc Technologies Appoints Executive Chairman Amir Heshmatpour as President

NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company’s New President

GlobeNewswire

7 months ago

NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company’s New President

MT Newswires

7 months ago

Sector Update: Health Care Stocks Fall Premarket Wednesday

MT Newswires

7 months ago

NeOnc Technologies Phase 1 Trial Enrollment for NEO212 Brain Cancer Drug Nears Full Enrollment

NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy

GlobeNewswire

7 months ago

NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy

MT Newswires

7 months ago

NeOnc Technologies Holdings' Perillyl Alcohol Receives FDA's Rare Pediatric Disease Designation

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas

GlobeNewswire

7 months ago

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas

NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments

GlobeNewswire

7 months ago

NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments

Share on Social Networks: